Emergency Medicine Doctors in Camp Pendleton, CA Accepting Medicare

9 Emergency Medicine doctors found. Showing 1 - 9

Dr. Michael Andrew Galuska, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Building H100, Naval Hospital Camp Pendleton, Camp Pendleton, CA 92055 Phone: 760-725-1620

Dr. Theomal Devinda Kurera, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Santa Margarita Road, Camp Pendleton, CA 92055 Phone: 760-725-1620

Dr. Richard Kevin Roach, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Naval Hospital Camp Pendleton, Bldg H100,santa Margarita Road, Camp Pendleton, CA 92055 Phone: 760-725-1620

Dr. Ed Hessel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1st Marine Division, Box 555380, Camp Pendleton, CA 92055 Phone: 760-725-5209

Dr. Felipe Humberto Grimaldo Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Mercy Circle, Camp Pendleton, CA 92055 Phone: 760-725-1288

Dr. Lisa Ann Kelty, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: H100 Santa Margerita Rd, Naval Hospital Camp Pendleton, Camp Pendleton, CA 92055 Phone: 904-343-4656

Dr. Amy Marie Pritchard, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Mercy Circle, Naval Hospital Camp Pendleton, Camp Pendleton, CA 92055 Phone: 760-719-4966

Stephen Alan Tschinkel, MD, MPH Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Mercy Cricle, Camp Pendleton, CA 92055 Phone: 760-719-3429

Dr. Mark D Hernandez, Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: Bldg, H100, Santa Margarita Road, Camp Pendleton, CA 92055 Phone: 760-725-8882    Fax: 760-725-1267

News Archive

PharMerica announces expiration of HSR Waiting Period to acquire Chem Rx

PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, announced today that the waiting period under the Hart-Scott-Rodino Act (the HSR Waiting Period) applicable to the bid to acquire substantially all of the assets of Chem Rx Corporation has expired.

Discovery points to clear, workable method to disrupt unwanted memories

The human brain is exquisitely adept at linking seemingly random details into a cohesive memory that can trigger myriad associations-some good, some not so good. For recovering addicts and individuals suffering from post-traumatic stress disorder, unwanted memories can be devastating. Former meth addicts, for instance, report intense drug cravings triggered by associations with cigarettes, money, even gum (used to relieve dry mouth), pushing them back into the addiction they so desperately want to leave.

Drive to make school nurses more accessible and confidential: UK

As part of a scheme by the Department of Health students may be getting to know their school nurses better. Using technology such as text messaging, emails and mobile phone apps to contact their school nurse could be used to overcome problems of setting up appointments.

Researchers discover potential treatment for viral infection that causes illnesses in children

Researchers have discovered a potential treatment for a viral infection that causes potentially fatal brain swelling and paralysis in children. The findings also point to possible treatments for related viruses including those that cause "common cold" symptoms.

Sequella to develop SQ109 further with EDCTP, LMU, and TB experts in PanACEA

Sequella, Inc., a clinical-stage company focused on commercializing novel drugs for treatment of life-threatening infectious diseases, announced it has signed an agreement with the Ludwig-Maximilians-University (LMU) of Munich to coordinate a European Union grant for Phase 2 clinical trials of SQ109 in adult pulmonary tuberculosis (TB) in seven sites in Africa.

Read more Medical News

› Verified 6 days ago